Clinical Trials Logo

Clinical Trial Summary

Graft versus host disease (GVHD) is a common complication of allogeneic stem cell transplant.Chronic GVHD is characterized by skin thickening and tightening. Advanced sclerosis can lead to reduced range of motion and incapacitating joint contractures. Once present, there are few therapeutic options. We will treat sclerosis and limb contractures with an ablative fractional laser, a device FDA-approved for scar treatment. This approach has successfully treated contracturesdue to burn scars.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02881047
Study type Interventional
Source Abramson Cancer Center of the University of Pennsylvania
Contact
Status Terminated
Phase N/A
Start date November 11, 2013
Completion date August 19, 2016